Found 0 matching trials
Effects of Mindful Eating on Female Nutrition Students
NAThe goal of this pilot randomized clinical trial is to evaluate the efficac...
Location
Universidade Federal de Uberlândia (UFU) - Campus Umuarama
VR to Reduce Pain/Anxiety During IV Starts
NAThis study aims to test the effectiveness of virtual reality (VR) as a non-...
Location
Children's Hospital Los Angeles
Pancreatic Adenocarcinoma Neoadjuvant Chemotherapy Before Surgery
PHASE2This is a single-arm, single-center feasibility trial of patients with bord...
Location
Juravinski Hospital
Evaluating Interventions for Breast Cancer Screening in Ghana
NAThis study aims to implement two interventions to determine the most effect...
Diabetes Data-Assisted Remission Trial (DDART)
NAThe study team will study the efficacy of a high intensity medical weight l...
Location
Wake Forest Univesity Health Sciences
HypErthermia as an Additional Treatment for the Biology and Experience of Depression
NAThis single-arm feasibility trial administered up to 8 weekly (early phase)...
Location
University of California San Francisco
Genetic Biomarkers for the Response to Anti-VEGF (Vascular Endothelial Growth Factor).Treatment in Wet Age-related Macular Degeneration (Wet ARMD)
NAAge-Related Macular Degeneration (ARMD) is the most common cause of blindne...
Personalising and Refining Neo-adjuvant Chemotherapy in Locally Advanced but Resecable Colon Cancer in the Elderly of 70 Years Old or More
PHASE3Colon cancer (CC) is the 5th most common cancer worldwide. Standard care fo...
Location
CHU Dijon Bourgogne
Use of Thalidomide, Lenalidomide, Carfilzomib, Bortezomib and Vorinostat in the Initial Treatment of Newly Diagnosed Multiple Myeloma Patients
PHASE3The purpose of this study is to compare a standard chemotherapy regimen of ...
Location
112 sites UK wide
Treatments Being Tested
Induction (intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone (CRD) regimenInduction (intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone (CTD) regimenInduction (intensive pathway) - carfilzomib, cyclophosphamide, lenalidomide, & dexamethasone (CCRD) regimenInduction (non-intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone attenuated (CRDa) regimenInduction (non-intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone attenuated (CTDa) regimenConsolidation (intensive & non-intensive pathways) - bortezomib, cyclophosphamide, & dexamethasone (VCD) regimenMaintenance (intensive & non-intensive pathways) - lenalidomide maintenanceMaintenance (intensive & non-intensive pathways - protocol v5.0 only) - lenalidomide plus vorinostat maintenanceHigh dose melphalan therapy and autologous stem cell transplant (intensive pathway only) Targeted vs Standard Fortification of Breast Milk
NABACKGROUND:
Human milk (HM) is recommended for all very low birth infants ...
Location
Department of Neonatology and Neonatal Intensive Care Warsaw Medical University